HNI vs MillerKnoll
HNI and MLKN side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HNI and MLKN compare
HNI is the larger company, worth 2.4 times as much as MillerKnoll ($3.5B against $1.5B).
On earnings, MillerKnoll is cheaper: it trades at 15.5× trailing earnings, against 446× for HNI.
HNI grew revenue faster over the last twelve months (70.1% versus 1.2% for MillerKnoll).
MillerKnoll keeps more of each dollar of sales as profit, with a net margin of 2.6% compared with 0.10% at HNI.
Both pay dividends: HNI yields 2.8% and MillerKnoll 3.4%.
MillerKnoll scores higher on the StockData Score (16 against 7 for HNI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HNI | MLKN |
|---|---|---|
| Size and price | ||
| Market cap | $3.5B | $1.5B |
| Share price | $49.02 | $21.84 |
| Change, 1 year | 24.4% | 54.9% |
| Change, 5 years | 18.5% | −48.0% |
| Beta (5Y) | 0.92 | 1.30 |
| Employees | 20K | 11K |
| StockData Score | ||
| Total score | 7 | 16 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 3 | 3 |
| Health score | 1 | 1 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 446× | 15.5× (better) |
| P/S | 0.8× | 0.4× (better) |
| P/B | 2.0× | 1.1× (better) |
| EV/EBITDA | 16.7× | 7.6× (better) |
| P/FCF | – | 13.0× |
| PEG | – | 0.46 |
| FCF yield | – | 7.7% |
| Fair value | $25.20 | $28.31 |
| Margin of safety | −94.5% | 22.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 70.1% (better) | 1.2% |
| Revenue growth, 5Y average | 7.7% | 9.3% (better) |
| Net income growth (TTM) | −97.1% | – |
| EPS growth (TTM) | −96.4% | – |
| EPS growth, 5Y average | 2.5% (better) | −14.8% |
| Profitability | ||
| Gross margin | 41.0% (better) | 39.5% |
| Operating margin | 2.0% | 5.2% (better) |
| Net margin | 0.10% | 2.6% (better) |
| FCF margin | – | 3.0% |
| Return on equity | 0.33% | 7.4% (better) |
| Return on invested capital | 2.1% | 6.0% (better) |
| Financial health | ||
| Debt / equity | 0.76 (better) | 0.96 |
| Net debt / EBITDA | 4.41 | 3.26 (better) |
| Interest coverage | – | 2.9× |
| Current ratio | 1.36 | 1.65 (better) |
| Altman Z-score | 1.77 | 1.85 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.8% | 3.4% (better) |
| Payout ratio | 1937% | 52.3% |
| Years of dividend growth | 15 (better) | 0 |
| Dividend growth, 5Y average | 2.0% | 6.0% (better) |
| Buyback yield | 0.01% (better) | −0.55% |
| Shareholder yield | 2.8% | 2.9% (better) |
| Ownership | ||
| Held by institutions | 87.8% | 96.4% |
| Held by insiders | 1.9% | 2.0% |
| Insider net buying, 12 months | −$4.8M | – |
| Short interest, % of float | 5.4% | 4.9% |
Go deeper
- HNI stock overview
- HNI income statement
- HNI valuation and score
- MLKN stock overview
- MLKN income statement
- MLKN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.